Format

Send to

Choose Destination
Circ Res. 2018 Jul 6;123(2):221-223. doi: 10.1161/CIRCRESAHA.118.312676.

At the Heart of Genome Editing and Cardiovascular Diseases.

Author information

1
From the Biological and Environmental Science and Engineering, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia (R.H.-B., P.M.).
2
Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA (R.H.-B., J.C.I.B.).
3
Universidad Católica San Antonio de Murcia, Spain (M.L.M.-M., J.L.).
4
Pluripotency for organ regeneration (PR Lab), Institute for Bioengineering of Catalonia, The Barcelona Institute of Science and Technology, Spain (N.M.).
5
and Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain (N.M.).
6
Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA (R.H.-B., J.C.I.B.) belmonte@salk.edu.

KEYWORDS:

atherosclerosis; cardiovascular diseases; cause of death; gene editing; induced pluripotent stem cells

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center